Thomas Bartlett
Myasthenia Gravis Patient Advocate Amgen Inc.
Before being diagnosed, I was the head of global sales for a life science consulting firm based in Boston. My background also includes Harvard, 18 years with Apple, and 4 years with Dell. While at Apple and Dell, my focus was in Research Computing Technology.
After being diagnosed with Myasthenia Gravis in 2019, I have spent the past seven years discussing how applied technologies measuring data in real time can improve the Quality of Life for rare patients.
Seminars
Thursday 25th March 2027
Beyond the Process: Bringing the Patient Voice into Expanded Access Programs
8:30 am
- Sharing a firsthand patient perspective on navigating serious disease and the importance of access to treatment options.
- Exploring the awareness gap surrounding Expanded Access Programs and why so few patients know these opportunities exist.
- Discussing how pharma, biotech, patient advocacy groups, and healthcare providers can work together to improve awareness, communication, and patient engagement around Expanded Access Programs
